Form 4: Allovir CFO Vikas Sinha Sells Shares to Cover Tax Obligations

Vikas Sinha, CFO of Allovir, sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Vikas Sinha, the President and CFO of Allovir, Inc., reported the sale of Allovir common stock on October 21 and 22, 2024.
• The sales were executed to cover tax withholding obligations related to the vesting of restricted stock units.
• On October 21, 2024, 1,546 shares were sold at a weighted average price of $0.779, with prices ranging from $0.7544 to $0.7964.
• On October 22, 2024, 1,882 shares were sold at a weighted average price of $0.7678, with prices ranging from $0.76 to $0.7709.
• Following the reported transactions, Sinha directly owns 1,149,216 shares of Allovir common stock.
• Sinha also indirectly owns 16,674,766 shares through ElevateBio LLC, where he serves as a director and CFO, but disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating routine stock sales for tax purposes. It doesn't convey any particularly positive or negative sentiment about the company's prospects.

Industry Context

Sales of shares to cover tax obligations are a routine part of equity compensation for company executives. It is a normal part of doing business and is not necessarily indicative of the company's financial health or future prospects.

Key Dates